Number of Shares
249,804.00
Current Holdings Value*
$9.05 Mil
% of Portfolio
2.36%
Total Estimate Gain
$-7.51 Mil
% of Total Estimate Gain
-44.24%

Privium Fund Management B.V.'s Ultragenyx Pharmaceutical Inc Holding Summary

As of 2025-03-31, Privium Fund Management B.V. held 249,804.00 shares of Ultragenyx Pharmaceutical Inc(RARE), totaling $9.05 Mil. This investment constitutes 2.36% of their stock portfolio, and Privium Fund Management B.V. now holds 0.26% of the outstanding Ultragenyx Pharmaceutical Inc(RARE) stock.

The initial trade took place in 2021Q4. And since then Privium Fund Management B.V. has made 9 purchases of RARE, at an average price of $56.99, for a total of 297,856.00 shares. In addition, there have been 4 sales at an average price of $51.24 for 48,052.00 shares. Based on historical transaction data and RARE's current price of $28.04, Privium Fund Management B.V.'s estimated gain on his RARE holdings is $-7.51 Mil, reflecting a -44.24% gain to date.

Privium Fund Management B.V. RARE ($28.04) Holding Chart

Privium Fund Management B.V. RARE ($28.04) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1